BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

510 related articles for article (PubMed ID: 17240501)

  • 21. Psychosocial treatments for people with co-occurring severe mental illnesses and substance use disorders (dual diagnosis): a review of empirical evidence.
    Horsfall J; Cleary M; Hunt GE; Walter G
    Harv Rev Psychiatry; 2009; 17(1):24-34. PubMed ID: 19205964
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High potency cannabis: a risk factor for dependence, poor psychosocial outcomes, and psychosis.
    Hall W; Degenhardt L
    BMJ; 2015 Mar; 350():h1205. PubMed ID: 25739398
    [No Abstract]   [Full Text] [Related]  

  • 23. The impact of alcohol and illicit drugs on people with psychosis: the second Australian National Survey of Psychosis.
    Moore E; Mancuso SG; Slade T; Galletly C; Castle DJ
    Aust N Z J Psychiatry; 2012 Sep; 46(9):864-78. PubMed ID: 22472772
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cannabinoids and mental health].
    Soyka M
    Schmerz; 2003 Aug; 17(4):268-73. PubMed ID: 12923676
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Psychosis among substance users.
    Thirthalli J; Benegal V
    Curr Opin Psychiatry; 2006 May; 19(3):239-45. PubMed ID: 16612208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Schizophrenia and cannabis consumption: epidemiology and clinical symptoms].
    Jockers-Scherübl MC
    Prax Kinderpsychol Kinderpsychiatr; 2006; 55(7):533-43. PubMed ID: 17058779
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reasons for cannabis use in men with and without psychosis.
    Green B; Kavanagh DJ; Young RM
    Drug Alcohol Rev; 2004 Dec; 23(4):445-53. PubMed ID: 15763749
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Addiction and schizophrenia. Nosological, clinical and therapeutic questions. 2. Substance dependence and schizophrenia].
    Soyka M
    Fortschr Neurol Psychiatr; 1994 Jun; 62(6):186-96. PubMed ID: 8050773
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Consumption patterns and motivation for use of addictive drugs in schizophrenic patients].
    Lambert M; Haasen C; Mass R; Krausz M
    Psychiatr Prax; 1997 Jul; 24(4):185-9. PubMed ID: 9340658
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Comorbidity of alcohol-substance use disorders in schizophrenia: a review].
    Evren EC; Evren B
    Turk Psikiyatri Derg; 2003; 14(3):213-24. PubMed ID: 14569472
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Significant relationship between lifetime alcohol use disorders and suicide attempts in an Australian schizophrenia sample.
    McLean D; Gladman B; Mowry B
    Aust N Z J Psychiatry; 2012 Feb; 46(2):132-40. PubMed ID: 22311529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between cannabis and psychosis: Reasons for use and associated clinical variables.
    Mané A; Fernández-Expósito M; Bergé D; Gómez-Pérez L; Sabaté A; Toll A; Diaz L; Diez-Aja C; Perez V
    Psychiatry Res; 2015 Sep; 229(1-2):70-4. PubMed ID: 26235479
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The neuropsychology of cannabis and other substance use in schizophrenia: review of the literature and critical evaluation of methodological issues.
    Coulston CM; Perdices M; Tennant CC
    Aust N Z J Psychiatry; 2007 Nov; 41(11):869-84. PubMed ID: 17924240
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Why schizophrenic patients use psychoactive substances?].
    Sawicka M
    Psychiatr Pol; 2004; 38(4):723-6. PubMed ID: 15518319
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential effects of sex on substance use between first episode psychosis patients and healthy people.
    Núñez C; Ochoa S; Huerta-Ramos E; Baños I; Barajas A; Dolz M; Sánchez B; Del Cacho N; ; Usall J
    Compr Psychiatry; 2016 Aug; 69():169-78. PubMed ID: 27423358
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Familial predisposition for psychiatric disorder: comparison of subjects treated for cannabis-induced psychosis and schizophrenia.
    Arendt M; Mortensen PB; Rosenberg R; Pedersen CB; Waltoft BL
    Arch Gen Psychiatry; 2008 Nov; 65(11):1269-74. PubMed ID: 18981338
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cannabis and psychosis: an update on course and biological plausible mechanisms.
    Linszen D; van Amelsvoort T
    Curr Opin Psychiatry; 2007 Mar; 20(2):116-20. PubMed ID: 17278907
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The temporal dynamics of relationships between cannabis, psychosis and depression among young adults with psychotic disorders: findings from a 10-month prospective study.
    Degenhardt L; Tennant C; Gilmour S; Schofield D; Nash L; Hall W; McKay D
    Psychol Med; 2007 Jul; 37(7):927-34. PubMed ID: 17288638
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stimulant and other substance use disorders in schizophrenia: prevalence, correlates and impacts in a population sample.
    Sara GE; Burgess PM; Malhi GS; Whiteford HA; Hall WC
    Aust N Z J Psychiatry; 2014 Nov; 48(11):1036-47. PubMed ID: 24819935
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cannabis abuse is associated with decision-making impairment among first-episode patients with schizophrenia-spectrum psychosis.
    Mata I; Rodríguez-Sánchez JM; Pelayo-Terán JM; Pérez-Iglesias R; González-Blanch C; Ramírez-Bonilla M; Martínez-García O; Vázquez-Barquero JL; Crespo-Facorro B
    Psychol Med; 2008 Sep; 38(9):1257-66. PubMed ID: 18005495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.